165 related articles for article (PubMed ID: 5360135)
1. [Reduction of post-prostatectomy bleeding by medication (experience with the antifibrinolytic agent AMCA)].
Kaufmann J; Siefker K
Urologe; 1969; 8(2):57-9. PubMed ID: 5360135
[No Abstract] [Full Text] [Related]
2. [Action of tranexamic acid on pre and post-operative bleeding after prostatic adenomectomy (double blind study)].
Raymond G; Fournier P; Cazenave G
J Urol Nephrol (Paris); 1973; 79(10-11):958-62. PubMed ID: 4140917
[No Abstract] [Full Text] [Related]
3. Control of bleeding during and after prostatectomy.
Fam A
Int Surg; 1971 Nov; 56(5):352-61. PubMed ID: 5315847
[No Abstract] [Full Text] [Related]
4. Fibrinolysis in surgery : personal experience with chest operations.
Aguilar HD
Indian J Chest Dis; 1974 Sep; 16 Suppl():310-21. PubMed ID: 4442936
[No Abstract] [Full Text] [Related]
5. Antifibrinolytic therapy with Cyklokapron in connection with prostatectomy. A double blind study.
Hedlund PO
Scand J Urol Nephrol; 1969; 3(3):177-82. PubMed ID: 4912802
[No Abstract] [Full Text] [Related]
6. Use of tranexamic acid, AMCA for the improvement of hemorrhagic manifestations in hemophilia.
Donner L; Klener P
Vnitr Lek; 1971 Sep; 17(9):846-50. PubMed ID: 5129130
[No Abstract] [Full Text] [Related]
7. Antifibrinolytic therapy in genitourinary tract surgery.
Andersson L
J Clin Pathol Suppl (R Coll Pathol); 1980; 14():60-2. PubMed ID: 6933158
[No Abstract] [Full Text] [Related]
8. AMCA (aminomethyl cyclohexane carboxylic acid, Cyklo-kapron) a potent haemostatic agent in urinary tract bleeding.
Andersson L; Nilsson IM
Scand J Urol Nephrol; 1969; 3(3):169-76. PubMed ID: 5393836
[No Abstract] [Full Text] [Related]
9. [Antifibrinolytic therapy in prostatectomies, tonsillectomies and adenotomies].
Ennemoser D; Heidbrink D
Med Welt; 1969 Apr; 17():1028-30. PubMed ID: 5784739
[No Abstract] [Full Text] [Related]
10. [On the use of antifibrinolytic agents in urology].
Rosdy E; Biró J; Szendröi Z; Szabó V
Acta Chir Acad Sci Hung; 1969; 10(1):25-35. PubMed ID: 5800598
[No Abstract] [Full Text] [Related]
11. [Antifibrinolytic and antihemorrhagic activity of trans-aminomethyl cyclohexane carboxylic acid (AMCHA). Clinical experience].
Avanzi G
Minerva Med; 1972 Dec; 63(87):4758-66. PubMed ID: 4565687
[No Abstract] [Full Text] [Related]
12. [Therapy of an experimentally induced radiation syndrome in the rat using brain phospholipids and an antifibrinolytic agent (AMCHA)].
Spreafico PL; Galetti G; Cuttin S
Arzneimittelforschung; 1973 Mar; 23(3):441-4. PubMed ID: 4740134
[No Abstract] [Full Text] [Related]
13. [On the use of AMCHA in the prevention and correction of hyperfibrinolysis in prostate surgery].
Consoli C; Di Grazia G; Terranova R; Lanzafame A
Minerva Urol; 1969; 21(6):214-23. PubMed ID: 4104301
[No Abstract] [Full Text] [Related]
14. Tranexamic acid in the control of spontaneous bleeding in severe haemophilia.
Rainsford SG; Jouhar AJ; Hall A
Thromb Diath Haemorrh; 1973 Nov; 30(2):272-9. PubMed ID: 4773366
[No Abstract] [Full Text] [Related]
15. Husbandry of blood products; the clinical use of cyklokapron.
O'Shea MJ; Flute PT
Br J Haematol; 1969 Dec; 17(6):612-3. PubMed ID: 5390684
[No Abstract] [Full Text] [Related]
16. Effect of tranexamic acid (AMCA) in menorrhagia with intrauterine contraceptive devices.
Weström L; Bengtsson LP
J Reprod Med; 1970 Oct; 5(4):154-61. PubMed ID: 4940818
[No Abstract] [Full Text] [Related]
17. [Use of Transamine, new antifibrinolytic agent. Its use in gynecology, obstetrics and surgery].
Lemgruber I; Maywald V
Hospital (Rio J); 1970 Jan; 77(1):107-18. PubMed ID: 5309987
[No Abstract] [Full Text] [Related]
18. [Value of tranexamic acid in extracapsular tonsillectomy in adults].
Mazauric FX; Boudon A; Rheingold C
JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1973 Feb; 22(2):165-8. PubMed ID: 4267424
[No Abstract] [Full Text] [Related]
19. Use of antifibrinolytic therapy in prostate surgery.
Shukla KK; Ambastha SS; Dube RK; Dube B
Int Surg; 1979 Mar; 64(2):79-81. PubMed ID: 317280
[TBL] [Abstract][Full Text] [Related]
20. Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA.
Andersson L; Nilsoon IM; Colleen S; Granstrand B; Melander B
Ann N Y Acad Sci; 1968 Jun; 146(2):642-58. PubMed ID: 5254275
[No Abstract] [Full Text] [Related]
[Next] [New Search]
